What does CUSIP 00182C103 represent in this 13F holders report?

CUSIP 00182C103 is the security identifier for ANIP - ANI PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ANIP - ANI PHARMACEUTICALS INC - Common Stock in Q2 2020?

124 institutional investors reported ANIP - ANI PHARMACEUTICALS INC - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 22,278,088
Total 13F shares: 7,466,801
Share change: -503,610
Total reported value: $241,329,748
Put/Call ratio: 103%
Price per share: $32.34
Number of holders: 124
Value change: -$25,517,337
Number of buys: 57
Number of sells: 66

Quarterly Holders Quick Answers

What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 00182C103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	6.5%	1,456,849	$59,352,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	2.7%	590,535	$24,058,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.3%	502,159	$20,458,000	—	31 Mar 2020	13F
MANGROVE PARTNERS IM, LLC	13F	Company	1.9%	426,162	$17,362,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	1.5%	325,353	$13,255,000	—	31 Mar 2020	13F
INVESTMENT COUNSELORS OF MARYLAND LLC	13F	Company	1.3%	284,437	$11,588,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.3%	281,421	$11,465,000	—	31 Mar 2020	13F
FIRST MANHATTAN CO. LLC.	13F	Company	1.2%	269,876	$10,994,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	1.2%	266,096	$10,841,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.2%	262,300	$10,686,000	—	31 Mar 2020	13F
Global Alpha Capital Management Ltd.	13F	Company	0.98%	217,746	$8,871,000	—	31 Mar 2020	13F
HAWK RIDGE CAPITAL MANAGEMENT LP	13F	Company	0.88%	196,661	$8,012,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.61%	136,276	$5,551,000	—	31 Mar 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.59%	131,512	$5,353,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.59%	131,397	$5,353,000	—	31 Mar 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.56%	125,678	$5,120,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.56%	123,924	$5,048,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.47%	104,669	$4,265,000	—	31 Mar 2020	13F
Ranger Investment Management, L.P.	13F	Company	0.44%	97,111	$3,956,000	—	31 Mar 2020	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.42%	93,123	$3,794,000	—	31 Mar 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.36%	80,721	$3,289,000	—	31 Mar 2020	13F
LSV ASSET MANAGEMENT	13F	Company	0.32%	71,500	$2,912,000	—	31 Mar 2020	13F
Man Group plc	13F	Company	0.31%	70,082	$2,855,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.31%	70,036	$2,853,000	—	31 Mar 2020	13F
Foundry Partners, LLC	13F	Company	0.31%	69,270	$2,822,000	—	31 Mar 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.27%	60,412	$2,461,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.26%	58,846	$2,397,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.26%	58,422	$2,381,000	—	31 Mar 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.26%	57,253	$2,332,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.25%	56,640	$2,308,000	—	31 Mar 2020	13F
THB ASSET MANAGEMENT	13F	Company	0.24%	52,964	$2,157,000	—	31 Mar 2020	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.23%	50,513	$2,059,000	—	31 Mar 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.2%	44,844	$1,826,000	—	31 Mar 2020	13F
Regent Investment Management LLC	13F	Company	0.18%	40,579	$1,653,000	—	31 Mar 2020	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.17%	38,155	$1,554,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.16%	35,571	$1,449,000	—	31 Mar 2020	13F
HUSSMAN STRATEGIC ADVISORS, INC.	13F	Company	0.16%	35,500	$1,446,000	—	31 Mar 2020	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.16%	34,700	$1,430,444	—	31 Mar 2020	13F
QS Investors, LLC	13F	Company	0.16%	35,100	$1,430,000	—	31 Mar 2020	13F
SEIZERT CAPITAL PARTNERS, LLC	13F	Company	0.16%	34,871	$1,421,000	—	31 Mar 2020	13F
Allianz Asset Management GmbH	13F	Company	0.16%	34,653	$1,412,000	—	31 Mar 2020	13F
CADENCE CAPITAL MANAGEMENT LLC	13F	Company	0.14%	32,168	$1,311,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.14%	31,700	$1,291,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.13%	28,786	$1,173,000	—	31 Mar 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.12%	27,726	$1,130,000	—	31 Mar 2020	13F
BESSEMER GROUP INC	13F	Company	0.12%	26,700	$1,088,000	—	31 Mar 2020	13F
York State Teachers Retirement System New	13F	Individual	0.11%	25,280	$1,030,000	—	31 Mar 2020	13F
1492 Capital Management LLC	13F	Company	0.11%	25,070	$1,021,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.11%	24,984	$1,018,000	—	31 Mar 2020	13F
Legal & General Group Plc	13F	Company	0.11%	23,609	$961,000	—	31 Mar 2020	13F

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q2 2020

As of 30 Jun 2020, ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,466,801 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, FEDERATED HERMES, INC., THOMPSON SIEGEL & WALMSLEY LLC, INVESTMENT COUNSELORS OF MARYLAND LLC, Global Alpha Capital Management Ltd., GOLDMAN SACHS GROUP INC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 124 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

135

Q2 2020 holders

124

Holder diff

-11

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.